Cocrystal Pharma, Inc. (COCP) shares rose 14.23 percent to $1.64 on Friday, adding $0.20, after the company announced it had entered into definitive agreements for a registered direct offering of 2.76 million shares at $1.70 per share, along with a concurrent private placement of unregistered warrants to purchase up to 5.53 million shares at $1.50 per share. The stock opened at $2.45 and traded between $1.54 and $2.67, compared with a prior close of $1.44 on the Nasdaq. Trading volume surged to 79.3 million shares, slightly above the average of 76,645. Cocrystal Pharma now trades within a 52-week range of $1.12 to $3.26.
The closing is expected on or about September 15, 2025.
For comments and feedback contact: editorial@rttnews.com
Business News
May 15, 2026 15:25 ET Apart from the confirmation of Kevin Warsh as the next Fed chair, the main news on the economics front this week included key price data from the U.S. and the first quarter economic growth figures from major economies. Both consumer prices and producer costs have started to reflect the effect of supply shocks due to the Middle East conflict. In Europe, GDP data was in focus, while inflation data from China dominated the news flow in Asia.